proline has been researched along with Cancer of Gallbladder in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, RF; Cao, Y; Chen, L; Hu, YP; Jiang, L; Li, HF; Liang, HB; Liu, SB; Liu, YB; Ma, Q; Shu, YJ; Wang, XA; Wang, Z; Xu, Y; Zhang, F; Zhang, YC; Zhang, YJ; Zhao, S; Zhou, J | 1 |
1 other study(ies) available for proline and Cancer of Gallbladder
Article | Year |
---|---|
The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Disease Progression; ErbB Receptors; Female; Gallbladder Neoplasms; Humans; Male; Mice; Mice, Nude; Mutation; Neoplasm Invasiveness; Neoplasm Transplantation; Prognosis; Proline; Protein Binding; Signal Transduction; Survival Analysis; Thiazoles | 2016 |